Jeffrey Strovel
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
- Wnt/β-catenin signaling in development and cancer
Papers in
-
- Protein Degradation and Inhibitors 9
- Histone Deacetylase Inhibitors Research 5
- Biochemical and Molecular Research 4
- Hematology 10
- Multiple Myeloma Research and Treatments 7
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Makoto Yoshioka (7 shared papers)Steven Fletcher (5 shared papers)Mithun Raje (2 shared papers)Jeremy L. Yap (1 shared paper)Maryanna E. Lanning (1 shared paper)Lijia Chen (1 shared paper)Eishi Ashihara (6 shared papers)Paul Yarowsky (1 shared paper)
- Journals
- Blood (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Clinical Oncology (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Jeffrey Strovel
23 papers receiving 338 citations
Peers
Comparison fields: 5 of 62
- Hematology 97
- Molecular Biology 264
- Oncology 61
- Genetics 22
- Cancer Research 28
Countries citing papers authored by Jeffrey Strovel
This map shows the geographic impact of Jeffrey Strovel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Strovel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Strovel more than expected).
Fields of papers citing papers by Jeffrey Strovel
This network shows the impact of papers produced by Jeffrey Strovel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Strovel. The network helps show where Jeffrey Strovel may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Strovel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 73 | |
| 2 | 2018 | 44 | |
| 3 | 2011 | 42 | |
| 4 | Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies | 2016 | 27 |
| 5 | 1999 | 24 | |
| 6 | 2011 | 18 | |
| 7 | 2017 | 17 | |
| 8 | 1999 | 15 | |
| 9 | 2018 | 13 | |
| 10 | 2018 | 10 | |
| 11 | 2019 | 10 | |
| 12 | 2006 | 10 | |
| 13 | 2021 | 10 | |
| 14 | 2005 | 8 | |
| 15 | 2008 | 3 | |
| 16 | 2007 | 3 | |
| 17 | Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection. | 1998 | 3 |
| 18 | 2008 | 3 | |
| 19 | Antiangiogenic properties of the IMPDH inhibitor AVN944 | 2007 | 2 |
| 20 | 2009 | 2 |
About Jeffrey Strovel
Jeffrey Strovel is a scholar working on Molecular Biology, Hematology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Genetics, having authored 24 papers that have together received 340 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Multiple Myeloma Research and Treatments (7 papers), Histone Deacetylase Inhibitors Research (5 papers), Biochemical and Molecular Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Computational Drug Discovery Methods (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (97 citations), Molecular Biology (264 citations), Oncology (61 citations), Genetics (22 citations) and Cancer Research (28 citations). Jeffrey Strovel has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Makoto Yoshioka, Steven Fletcher, Mithun Raje, Jeremy L. Yap, Maryanna E. Lanning, Lijia Chen, Eishi Ashihara, Paul Yarowsky, J. Stamberg and Janak Padia. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry Letters, Journal of Clinical Oncology, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.